CLINICAL_TRIALS
trial_result
· 2013-03-13
Clinical Trial Update: A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants [Phase 3]
Summary
Phase 3 safety and efficacy results for oral tapentadol extended-release in Japanese participants.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2013-03-13